DHODH-IN-11 is primarily used in research settings to study its potential as an inhibitor of dihydroorotate dehydrogenase (DHODH), an enzyme involved in the de novo pyrimidine biosynthesis pathway. By targeting this enzyme, it has shown promise in preclinical studies for its ability to suppress the proliferation of rapidly dividing cells, such as those found in certain cancers or autoimmune diseases. Researchers are exploring its efficacy in models of leukemia, rheumatoid arthritis, and other conditions where DHODH activity plays a critical role. Additionally, it serves as a valuable tool for understanding the biochemical mechanisms of DHODH inhibition and its downstream effects on cellular metabolism.